Gaelic Laboratories buys Athlone to scale Irish beta-lactam manufacturing

Irish pharma manufacturer Gaelic Laboratories has acquired Athlone Laboratories, another Irish producer focused on oral dose beta-lactam antibiotics. The transaction brings together two established domestic manufacturers as demand for established antibiotics remains resilient across hospital and outpatient settings.

The combined group aims to expand manufacturing capacity, improve supply chain efficiency and broaden product offerings in beta-lactams, including widely used penicillins such as amoxicillin and ampicillin. All existing product lines and customer contracts are expected to continue without disruption.

Gaelic said it will retain Athlone’s workforce and management team, with Athlone’s executive leadership reporting to Brian Morrissey, general manager of Gaelic Laboratories. The acquisition increases the group’s total workforce to around 120 people.